Erkang Pharmaceutical: Notice on convening the first extraordinary shareholders' meeting in 2025
Securities code: 300267 Securities abbreviation: Erkang Pharmaceutical Announcement number: 2025-039
Hunan Erkang Pharmaceutical Co., Ltd.
Notice on Convening the First Extraordinary General Meeting of Shareholders in 2025
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete, and contains no false records, misleading statements or major omissions.
1. Basic information on convening the meeting
Session of the general meeting of shareholders: the first extraordinary general meeting of shareholders in 2025
Convener of the shareholders’ meeting: Board of Directors
The convening and holding of this meeting complied with the relevant provisions of the "Company Law of the People's Republic of China", "Shenzhen Stock Exchange GEM Stock Listing Rules", "Shenzhen Stock Exchange Self-Regulatory Guidelines for Listed Companies No. 2 - Standardized Operation of GEM Listed Companies" and other laws, administrative regulations, departmental rules, normative documents and the "Articles of Association".
Meeting time:
(1) On-site meeting time: 14:30 on November 14, 2025
(2) Online voting time: The specific time for online voting through the Shenzhen Stock Exchange system is 9:15-9:25, 9:30-11:30, 13:00-15:00 on November 14, 2025; the specific time for voting through the Shenzhen Stock Exchange’s Internet voting system is any time from 9:15 to 15:00 on November 14, 2025.
How the meeting will be held: a combination of on-site voting and online voting.
Equity registration date for the meeting: November 10, 2025
Participants:
(1) As of the market close on the afternoon of November 10, 2025 (Monday), the equity registration date, all shareholders of the company registered with the Shenzhen Branch of China Securities Depository and Clearing Co., Ltd. All shareholders of the above-mentioned companies have the right to attend the general meeting of shareholders and may entrust a proxy in writing to attend the meeting and participate in voting. The shareholder proxy does not have to be a shareholder of the company. (2) Directors, supervisors and senior managers of the company.
(3) Witnessing lawyers and related personnel hired by the company.
- Meeting location: Conference room on the first floor of the company's office building (No. 1 Industrial Road, Kaiyuan Avenue, North Park, Liuyang Industrial Park, Changsha City, Hunan Province)
2. Matters to be considered at the meeting
- Coding list of proposals for this general meeting of shareholders
Remarks Proposal Code Proposal Name Proposal Type Columns checked in this column can be voted on
Total proposals: all except cumulative voting proposals
100 non-cumulative voting proposals √
proposal
1.00 "Proposal on Amending the Articles of Association" Non-cumulative voting proposal √
"Proposal on Amending Part of the Company's Governance System" Sub-2.00 Non-Cumulative Voting Proposal Targeted for Voting
"Proposal" Number of proposals (9) 2.01 Revise the "Rules of Procedures of the Shareholders' Meeting" Non-cumulative voting proposal √ 2.02 Revise the "Rules of Procedures of the Board of Directors" Non-cumulative voting proposal √ 2.03 Revise the "Working System of Independent Directors" Non-cumulative voting proposal √ 2.04 Revise the "Related Transaction Management System" Non-cumulative voting proposal √ 2.05 Revise the "External Investment Management Measures" Non-cumulative voting proposal √ 2.06 Revise the "External Guarantee Management Measures" Non-cumulative voting proposal √ 2.07 Revise the "Accounting Firm Selection and Employment System" Non-cumulative voting proposal √ 2.08 Revise the "Regulations on the Management of Raised Funds" Non-cumulative voting proposal √ 2.09 Revise the "Major Investment and Financial Decision-making System" Non-cumulative voting proposal √
"About the election of non-independent directors of the sixth session of the Board of Directors"
3.00 Cumulative voting proposal Number of candidates (3) Personnel proposal》
Elected Mr. Shuai Fangwen as the sixth director of the company
3.01 Cumulative voting proposal √Meet non-independent directors
Elected Ms. Shi Xiangyan as the sixth director of the company
3.02 Cumulative voting proposal √Meet non-independent directors
Mr. Sun Qingrong was elected as the sixth director of the company
3.03 Cumulative voting proposal √Meet non-independent directors
"About the Election of Independent Directors of the Sixth Board of Directors"
4.00 Cumulative voting proposal Proposal for the number of candidates (3)
Mr. Tan Xue was elected as the company’s sixth board of directors
4.01 Cumulative voting proposal √Independent Director
Elected Mr. Liu Tiefan as the sixth director of the company
4.02 Cumulative voting proposal √
independent director
Mr. Wu Yong was elected as the company’s sixth board of directors
4.03 Cumulative voting proposal √
independent director
The above proposal has been reviewed and approved at the 16th meeting of the fifth session of the board of directors of the company. For details, please refer to the information disclosure website designated by the China Securities Regulatory Commission.
Proposals 1, 2.01 and 2.02 are special resolution matters and must be passed by more than 2/3 of the voting rights held by shareholders (including shareholders’ agents) present at the shareholders’ meeting.
Proposal 3 and Proposal 4 adopt a cumulative voting system to vote item by item, and 3 non-independent directors and 3 independent directors should be elected. The number of electoral votes owned by a shareholder is the number of shares with voting rights multiplied by the number of candidates for election. The number of electoral votes owned by a shareholder can be distributed arbitrarily among the candidates within the limit of the number of candidates for election (zero votes can be cast), but the total number of electoral votes must not exceed the number of electoral votes it possesses. Among them, Proposal 4: The qualifications and independence of independent director candidates must be reviewed and approved by the Shenzhen Stock Exchange before being submitted to the shareholders' meeting for consideration.
The above proposals will be voted on item by item, and the company will count the votes of small and medium shareholders separately.
3. Meeting registration and other matters
Registration time: 9:00-12:00 am and 14:00-17:00 pm on November 11, 2025.
Registration location: Securities Department of Hunan Erkang Pharmaceutical Co., Ltd., No. 1 Industrial Road, Kaiyuan Avenue, North Park, Liuyang Industrial Park, Changsha City
Registration method
(1) Natural person shareholders register with their ID cards and securities account cards; agents register with their ID cards, copies of the client’s ID cards, copies of the client’s securities account cards, and a power of attorney signed by the client (Annex 3);
(2) The legal person shareholder representative shall register with the attendee’s personal identity card, legal representative qualification certificate or legal person’s power of attorney (Annex 3), securities account card and a copy of the business license stamped with the company’s official seal;
(3) Shareholders can register by letter, fax or door-to-door with the above relevant documents. Shareholders should carefully fill in the "Participating Shareholder Registration Form" (Appendix 2) for registration confirmation. (Registration must be received or faxed to the company before 17:00 pm on November 11, 2025).
(4) Shareholders or shareholders’ agents attending the on-site meeting should bring original relevant documents.
- Contact information
Contact person: Wang Rong
Contact number: 0731-83282597
Fax: 0731-83282705
Mailing address: Securities Department, Hunan Erkang Pharmaceutical Co., Ltd., No. 1 Industrial Road, Kaiyuan Avenue, North Park, Liuyang Industrial Park, Changsha, Hunan
Postal code: 410331
- The on-site meeting of this general meeting of shareholders will last for half a day, and participants will be responsible for their own expenses such as food, accommodation and transportation.
4. Specific operational procedures for participating in online voting
At this general meeting of shareholders, the company will provide shareholders with an online platform. Shareholders can participate in voting through the Shenzhen Stock Exchange trading system and the Internet voting system (http://wltp.cninfo.com.cn). The specific operating procedures for online voting are shown in Appendix 1.
5. Documents for reference
Resolution of the 16th meeting of the fifth board of directors
Other documents required by Shenzhen Stock Exchange
Announcement is hereby made.
Board of Directors of Hunan Erkang Pharmaceutical Co., Ltd.
October 29, 2025